Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant changes » significant challenge (Expand Search)
significant cause » significant change (Expand Search), significant gap (Expand Search), significant increase (Expand Search)
Showing 1,041 - 1,060 results of 21,342 for search '(( significant decrease decrease ) OR ( ((significant cause) OR (significant changes)) decrease ))', query time: 0.47s Refine Results
  1. 1041
    Fig 4 -

    Fig 4 - by Yasmin Mohd Zainal Abidin Shukri (20558861)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 1042
    HPLC data.

    HPLC data. by Yasmin Mohd Zainal Abidin Shukri (20558861)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 1043
    Fer-1 alleviated liver lesions caused by <i>C. sinensis.</i>

    Fer-1 alleviated liver lesions caused by <i>C. sinensis.</i> by Haoyang Zhang (1706815)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 1044
    Inhibition of ferroptosis alleviated liver fibrosis caused by <i>C. sinensis.</i>

    Inhibition of ferroptosis alleviated liver fibrosis caused by <i>C. sinensis.</i> by Haoyang Zhang (1706815)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 1045
    ALKG1202R –ABT199 interactions.

    ALKG1202R –ABT199 interactions. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 1046
    ALKC1156Y –ABT199 interactions.

    ALKC1156Y –ABT199 interactions. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 1047
    S1 Data -

    S1 Data - by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 1048
    Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.

    Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 1049
    Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.

    Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 1050
    Molecular docking showed that ABT-199 can fit into active site of ALK<sup>Mutant</sup>.

    Molecular docking showed that ABT-199 can fit into active site of ALK<sup>Mutant</sup>. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 1051
    The binding energy values of ATP, ALK inhibitors and ABT-199 to ALK were obtained from AlphaFold and modeled protein structures.

    The binding energy values of ATP, ALK inhibitors and ABT-199 to ALK were obtained from AlphaFold and modeled protein structures. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 1052
    Amino acids interactions and binding energy describe that ABT-199 binds to ALK<sup>Mutant</sup>.

    Amino acids interactions and binding energy describe that ABT-199 binds to ALK<sup>Mutant</sup>. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 1053
    Western blot analysis of drug combinations.

    Western blot analysis of drug combinations. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 1054
    ALKL1196M –ABT199 interactions.

    ALKL1196M –ABT199 interactions. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 1055
    ALK<sup>wt</sup>–ABT199 interactions.

    ALK<sup>wt</sup>–ABT199 interactions. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 1056
    BCL2 protein keeps their expression in different conditions treatment nevertheless each EML4-ALK cell modells exhibit variable expression.

    BCL2 protein keeps their expression in different conditions treatment nevertheless each EML4-ALK cell modells exhibit variable expression. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 1057
    ALK inhibitors (Positive control) and ABT199 (Proposed binding) in complex with the ALK active side.

    ALK inhibitors (Positive control) and ABT199 (Proposed binding) in complex with the ALK active side. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 1058
    BCL2 antiapoptotic protein exhibits heterogeneous expression in Ba/F3 EML4-ALK<sup>mutants</sup>.

    BCL2 antiapoptotic protein exhibits heterogeneous expression in Ba/F3 EML4-ALK<sup>mutants</sup>. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 1059
    Loewe synergy-antagonism score analysis shows additive and synergistic effects after ALKi and ABT-199 combination treatment.

    Loewe synergy-antagonism score analysis shows additive and synergistic effects after ALKi and ABT-199 combination treatment. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 1060
    Negative (Prednisone) and basal (ATP) control compounds binding to ALK protein.

    Negative (Prednisone) and basal (ATP) control compounds binding to ALK protein. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: